openPR Logo
Press release

Transforming Growth Factor Market to reach a valuation of approximately US$ 798.2 Million by the end of 2033

04-13-2023 10:28 AM CET | Health & Medicine

Press release from: Persistence Market Research

Transforming Growth Factor Market

Transforming Growth Factor Market

Transforming growth factor (TGF) is a multifunctional cytokine that plays a vital role in cellular growth, differentiation, and immune response. TGF is involved in various biological processes such as embryonic development, tissue repair, and wound healing. The transforming growth factor market has seen a significant increase in demand in recent years due to its potential therapeutic applications in various diseases.

The report highlights that the increasing prevalence of cancer and other chronic diseases, rising demand for biologics, and the growing research and development activities are the key factors driving the growth of the market.

Request for a Free Sample PDF Here@
https://www.persistencemarketresearch.com/samples/32813

The global revenue from the transforming growth factor market stands at US$ 362.7 Million in 2022, with the global market expected to grow at a CAGR of 7.4% to reach a valuation of approximately US$ 798.2 Million by the end of 2033.

Leading Players:
Thermo Fisher Scientific
Lonza Group AG
Merck KGaA
F. Hoffmann-La Roche Ltd
Abcam plc.
Bio-Techne.
Sartorius CellGenix GmbH
Proteintech Group, Inc.
PeproTech Inc.
Cell Signaling Technology, Inc.
Meridian Bioscience Inc.
Applied Biological Materials (abm), Inc.
Akron Biotech
Leadgene Biomedical, Inc
GE Healthcare

The market is segmented based on product type, application, and region. By product type, the market is divided into recombinant TGF-β1, recombinant TGF-β2, and others. The recombinant TGF-β1 segment is expected to dominate the market due to its potential therapeutic applications in various diseases such as cancer, fibrosis, and autoimmune disorders.

By application, the market is segmented into oncology, immunology, dermatology, cardiovascular diseases, and others. The oncology segment is expected to dominate the market due to the high prevalence of cancer and the growing research and development activities in this area.

By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market due to the high adoption of biologics and the presence of major market players in this region. Europe is expected to witness significant growth due to the increasing research and development activities and favorable government initiatives.

The market is also influenced by various trends such as the rising demand for personalized medicine, increasing focus on regenerative medicine, and the growing use of TGF in tissue engineering. With the increasing focus on regenerative medicine, there is a high demand for TGF for its potential therapeutic applications in tissue repair and regeneration.

Furthermore, with the increasing focus on personalized medicine, there is a growing demand for TGF for its potential role in the development of personalized therapies.

If You want to Purchase Specific Insights By Segment/Region/Competitor, Request For Customization@
https://www.persistencemarketresearch.com/request-customization/32813

The market is also witnessing various collaborations and partnerships between pharmaceutical companies and research institutes to develop innovative products and services for the healthcare industry. For instance, in 2020, the collaboration between Biogen and the University of California, San Francisco resulted in the development of a TGF-β inhibitor for the treatment of fibrosis and other chronic diseases.

In conclusion, the transforming growth factor market is expected to witness significant growth due to the increasing prevalence of chronic diseases, rising demand for biologics, and the growing research and development activities. With the potential therapeutic applications of TGF in various diseases, there is a high demand for innovative products and services that can improve patient outcomes.

The market is also influenced by various trends such as the rising demand for personalized medicine and the growing use of TGF in tissue engineering. The market is also witnessing various collaborations and partnerships between pharmaceutical companies and research institutes to develop innovative products and services for the healthcare industry.

If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @
https://www.persistencemarketresearch.com/checkout/32813

Contact
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Persistence Market Research:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transforming Growth Factor Market to reach a valuation of approximately US$ 798.2 Million by the end of 2033 here

News-ID: 3011447 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for TGF

Recombinant Biotinylated Human TGF-βRII Protein Market Research Report 2025: CA …
The global market for Recombinant Biotinylated Human TGF-βRII Protein was estimated to be worth US$ 12.00 million in 2024 and is forecast to a readjusted size of US$ 23.03 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031. QYResearch (Global Market Report Research Publisher) announces the release of 2025 latest report "Recombinant Biotinylated Human TGF-βRII Protein - Global Market Share and Ranking, Overall Sales and Demand Forecast
Recombinant Biotinylated Human TGF-βRII Protein Market Outlook 2025, Emerging T …
The global Recombinant Biotinylated Human TGF-βRII Protein Market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Recombinant Biotinylated Human TGF-βRII
TGF-Beta-1 Inhibitor Market 2020 Clinical Reviews by Expert and Healthcare Analy …
TGF-Beta-1 Inhibitor -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of TGF-Beta-1 Inhibitor Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has
Transforming Growth Factor (TGF) Inhibitor Market 2020 Competitive Analysis - El …
Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2020 report by comprehensive insights of present scenario and growth prospects across Transforming Growth Factor (TGF) Inhibitor. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. The report is a collection of pragmatic information, quantitative and qualitative estimation by experts, the
Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Prot …
Market Research Hub (MRH) has added a new report titled “Activin Receptor Type 1 Pharmaceutical Pipeline Research Report” to its vast data repository. Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) pipeline Target constitutes close to 9 molecules. Out of which approximately 8 molecules are developed by companies and
TGF Beta Receptor Type 1 - Pipeline Review, H1: Industry Overview, Trends and Gr …
“TGF Beta Receptor Type 1 Pipeline Review”, H2 2016, provides in depth analysis on TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30) targeted pipeline therapeutics. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=823150 The report provides comprehensive information on